Can ivabradine be given sublingually to a patient who is nil per os (NPO)?

No, Ivabradine Cannot Be Given Sublingually to NPO Patients

Ivabradine must be administered orally with food and cannot be given via sublingual route. 1

Route of Administration Requirements

The FDA-approved prescribing information for ivabradine explicitly states that the medication should be "taken 2 times each day with food" 1. The drug is formulated as:

• Film-coated tablets (5 mg and 7.5 mg)
• Oral solution (for patients unable to swallow tablets) 1

There is no sublingual formulation of ivabradine, and the standard oral tablets are not designed for sublingual administration.

Management of NPO Patients

When patients are NPO, Canadian stroke guidelines provide clear direction: "Oral medications should not be administered until swallowing screen using a validated tool has been completed and found normal; alternate routes such as intravenous and rectal administration should be considered while a patient is NPO" 2, 3.

Clinical Algorithm for NPO Patients Requiring Heart Rate Control:

1. If patient is NPO and requires heart rate reduction:

   • Consider intravenous beta-blockers (e.g., metoprolol, esmolol)
   • Consider intravenous diltiazem or verapamil (if no contraindications) 4
   • Do not attempt sublingual ivabradine - this route is not validated

2. Once swallowing assessment is completed and safe:

   • Resume oral ivabradine with food 2
   • For patients unable to swallow tablets, use ivabradine oral solution 1

3. If patient has feeding tube access:

   • Ivabradine oral solution may be administered via feeding tube (though specific FDA guidance should be confirmed)
   • Must still be given with nutrition/feeding

Important Caveats

• Food requirement is critical: Ivabradine's pharmacokinetics are affected by food intake, which is why administration with meals is mandated 1
• No emergency indication: Ivabradine is for chronic heart rate management in stable heart failure, not acute situations where NPO status would necessitate alternative routes 4, 5
• Sublingual absorption not studied: There is no evidence supporting efficacy, safety, or appropriate dosing via sublingual route

Bottom line: Hold ivabradine while patient is NPO, use alternative IV agents for acute heart rate control if needed, and resume oral ivabradine with food once safe swallowing is confirmed.